← Open Payments lookup

PAVEL BUZADZHI: Open Payments

NPI 1790318426 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$9,123 in 152 payments from 17 companies in 2025. Trend: 2023 $6,978 · 2024 $5,964 · 2025 $9,123

Food & beverage: $4,854Travel & lodging: $4,268
CompanyPaymentsAmount
Abbott Laboratories27$2,594
ABIOMED24$2,490
United Therapeutics Corporation21$1,548
CVRx, Inc.11$823
Alnylam Pharmaceuticals Inc.9$497
Merck Sharp & Dohme LLC11$295
AstraZeneca Pharmaceuticals LP9$209
PFIZER INC.14$162
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)7$131
Bayer Healthcare Pharmaceuticals Inc.5$114

Products named: CARDIOMEMS, Barostim Neo System, AMVUTTRA, Tyvaso, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, WINREVAIR, Remodulin, WAINUA.

Industry payments across OK — which companies pay providers there.